STOCK TITAN

Intercontinental Exchange: 184K shares sold under plan

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Intercontinental Exchange, Inc. (ICE) CEO Jeffrey C. Sprecher exercised options for 34,923 shares of common stock on November 17, 2026: 33,844 at an exercise price of $67 per share and 1,079 at $92.63 per share. Sales from Sprecher’s direct holdings and CPEX totaled 183,844 shares that day; the sales were made under a Rule 10b5-1 plan approved and effective August 18, 2026. Sprecher also gave 28,090 shares to a philanthropic organization.

Insider Sprecher Jeffrey C
Role Chief Executive Officer
Sold 183,844 shs ($32.00M)
Approx. gross sale proceeds $32.00M
Approx. exercise cost $2.37M
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) Holding F15 33,844 $0.00 $0.00
Exercise Employee Stock Option (right to buy) Holding F15 1,079 $0.00 $0.00
Exercise Common Stock F1, F2 33,844 $67.00 $2.27M
Exercise Common Stock F1 1,079 $92.63 $100K
Gift Common Stock F3 28,090 $0.00 $0.00
Sale Common Stock F1, F4 12,940 $172.2987 $2.23M
Sale Common Stock F1, F5 3,944 $173.2801 $683K
Sale Common Stock F1, F6 3,479 $174.399 $607K
Sale Common Stock F1, F7 8,040 $175.5072 $1.41M
Sale Common Stock F1, F8 4,745 $176.451 $837K
Sale Common Stock F1, F9, F10, F11, F12 696 $177.1351 $123K
Sale Common Stock F1, F4 57,377 $172.2986 $9.89M
Sale Common Stock F1, F5 17,500 $173.2802 $3.03M
Sale Common Stock F1, F6 15,390 $174.3975 $2.68M
Sale Common Stock F1, F7 35,611 $175.508 $6.25M
Sale Common Stock F1, F8 21,034 $176.4508 $3.71M
Sale Common Stock F1, F9, F13 3,088 $177.1359 $547K
Holding Common Stock F14 -- -- --
Holdings After Transaction: Employee Stock Option (right to buy) Holding — 195,715 options (Direct); Common Stock — 1,068,013 shares (Direct); Common Stock — 1,501,705 shares (Indirect, CPEX); Common Stock — 81,570 shares (Indirect, By spouse)
Footnotes (15)
  1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 18, 2026.
  2. F2. Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3. This transaction involved a gift of 28,090 shares of the issuer's common stock by the reporting person to a philanthropic organization.
  4. F4. The price range for the aggregate amount sold by the direct holder is $171.98 - $172.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5. The price range for the aggregate amount sold by the direct holder is $172.98 - $173.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  6. F6. The price range for the aggregate amount sold by the direct holder is $173.98 - $174.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  7. F7. The price range for the aggregate amount sold by the direct holder is $174.98 - $175.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  8. F8. The price range for the aggregate amount sold by the direct holder is $175.98 - $176.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  9. F9. The price range for the aggregate amount sold by the direct holder is $176.99 - $177.35. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  10. F10. The common stock number referred in Table I is an aggregate number and represents 1,007,733 shares of common stock and 46,016 unvested restricted stock units ("RSUs"), and 14,264 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  11. F11. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  12. F12. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  13. F13. As previously reported, the reporting person also indirectly owns 1,501,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  14. F14. As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  15. F15. These options are fully vested.
Shares sold 183,844 shares Sprecher’s direct holdings and CPEX, November 17, 2026
Shares acquired through option exercises 34,923 shares November 17, 2026; 33,844 at $67 per share and 1,079 at $92.63 per share
Shares gifted 28,090 shares Gift to a philanthropic organization, November 17, 2026
Rule 10b5-1 trading plan regulatory
"effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units (RSUs) financial
"unvested restricted stock units (RSUs)"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
performance based restricted stock units financial
"performance based restricted stock units (PSUs)"
Performance-based restricted stock units are a form of employee pay where shares are promised but only delivered if the company meets specific performance targets over time. Like a trophy awarded to a team after hitting certain goals, they align employee incentives with business results and can affect future share counts and earnings—so investors watch them for signals about management’s motivation, potential dilution, and the likelihood of meeting growth or profit targets.
EBITDA financial
"earnings before interest, taxes, depreciation, and amortization (EBITDA)"
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ICE shares did Jeffrey C. Sprecher sell?

Sprecher’s direct holdings and CPEX reported sales totaling 183,844 shares on November 17, 2026. The sales were made under a Rule 10b5-1 plan approved and effective August 18, 2026.

How many ICE shares did Jeffrey C. Sprecher acquire through option exercises?

Sprecher acquired 33,844 shares at an exercise price of $67 per share and 1,079 at $92.63 per share on November 17, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sprecher Jeffrey C

(Last)(First)(Middle)
5660 NEW NORTHSIDE DRIVE

(Street)
ATLANTA GEORGIA 30328

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Intercontinental Exchange, Inc. [ ICE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/17/2026M33,844(1)A$671,128,868(2)D
Common Stock11/17/2026M1,079(1)A$92.631,129,947D
Common Stock11/17/2026G28,090(3)D$01,101,857D
Common Stock11/17/2026S12,940(1)D$172.2987(4)1,088,917D
Common Stock11/17/2026S3,944(1)D$173.2801(5)1,084,973D
Common Stock11/17/2026S3,479(1)D$174.399(6)1,081,494D
Common Stock11/17/2026S8,040(1)D$175.5072(7)1,073,454D
Common Stock11/17/2026S4,745(1)D$176.451(8)1,068,709D
Common Stock11/17/2026S696(1)D$177.1351(9)1,068,013(10)(11)(12)D
Common Stock11/17/2026S57,377(1)D$172.2986(4)1,594,328ICPEX
Common Stock11/17/2026S17,500(1)D$173.2802(5)1,576,828ICPEX
Common Stock11/17/2026S15,390(1)D$174.3975(6)1,561,438ICPEX
Common Stock11/17/2026S35,611(1)D$175.508(7)1,525,827ICPEX
Common Stock11/17/2026S21,034(1)D$176.4508(8)1,504,793ICPEX
Common Stock11/17/2026S3,088(1)D$177.1359(9)1,501,705(13)ICPEX
Common Stock81,570(14)IBy spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) Holding$6711/17/2026M33,844 (15)02/08/2028Common Stock33,844$067,689D
Employee Stock Option (right to buy) Holding$92.6311/17/2026M1,079 (15)02/07/2030Common Stock1,079$0128,026D
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 18, 2026.
2. Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
3. This transaction involved a gift of 28,090 shares of the issuer's common stock by the reporting person to a philanthropic organization.
4. The price range for the aggregate amount sold by the direct holder is $171.98 - $172.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
5. The price range for the aggregate amount sold by the direct holder is $172.98 - $173.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
6. The price range for the aggregate amount sold by the direct holder is $173.98 - $174.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
7. The price range for the aggregate amount sold by the direct holder is $174.98 - $175.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
8. The price range for the aggregate amount sold by the direct holder is $175.98 - $176.97. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
9. The price range for the aggregate amount sold by the direct holder is $176.99 - $177.35. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
10. The common stock number referred in Table I is an aggregate number and represents 1,007,733 shares of common stock and 46,016 unvested restricted stock units ("RSUs"), and 14,264 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
11. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
12. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
13. As previously reported, the reporting person also indirectly owns 1,501,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
14. As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
15. These options are fully vested.
/s/ Octavia N. Spencer, Attorney-in-fact11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading